A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism
作者:
A.G. FENNERTY,
J. DOLBEN,
P. THOMAS,
G. BACKHOUSE,
D.P. BENTLEY,
I.A. CAMPBELL,
P.A. ROUTLEDGE,
期刊:
Clinical&Laboratory Haematology
(WILEY Available online 1987)
卷期:
Volume 9,
issue 1
页码: 17-21
ISSN:0141-9854
年代: 1987
DOI:10.1111/j.1365-2257.1987.tb01377.x
出版商: Blackwell Publishing Ltd
关键词: anticoagulants;thromboembolism
数据来源: WILEY
摘要:
SummaryOne hundred hospital in‐patients treated for pulmonary embolism (PE) and/or deep vein thrombosis (DVT) were randomly allocated to receive 3 or 6 weeks' anticoagulation with heparin and warfarin. At one year recurrence rates were 12% in the 6 week group and 10% in those treated for 3 weeks. No patient died as a result of recurrence. Our study suggests that 3 weeks' anticoagulation therapy, using intravenous heparin for the first 5 days and warfarin from the third day, is adequate for patients without persisting risk factor
点击下载:
PDF
(408KB)
返 回